drugset / Trial / NCT04333251

Study Testing Convalescent Plasma vs Best Supportive Care

NCT04333251 ↗

Phase 1 Withdrawn Baylor Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

Currently there are no proven treatment option for COVID-19. Human convalescent plasma is an option for COVID-19 treatment and could be available from people who have recovered and can donate plasma.

Timeline

Start
2020-04-17
Primary completion
2021-09-07
Completion
2021-09-07

Outcome

Outcome not reported

Stopped (Business): “Funding was not obtained and study was not activated”

Drugs

EvaluationDrugModalityDoseRoute
Subject high-titer anti-Sars-CoV-2 plasma Protein / enzyme biologic — —

Indications